These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Environmental microbial contamination in a stem cell bank. Cobo F; Concha A Lett Appl Microbiol; 2007 Apr; 44(4):379-86. PubMed ID: 17397475 [TBL] [Abstract][Full Text] [Related]
3. Airborne particle monitoring in clean room environments for stem cell cultures. Cobo F; Grela D; Concha A Biotechnol J; 2008 Jan; 3(1):43-52. PubMed ID: 18034434 [TBL] [Abstract][Full Text] [Related]
4. Environmental monitoring programme in the cell therapy facility of a research centre: preliminary investigation. Ottria G; Dallera M; Aresu O; Manniello MA; Parodi B; Spagnolo AM; Cristina ML J Prev Med Hyg; 2010 Dec; 51(4):133-8. PubMed ID: 21553557 [TBL] [Abstract][Full Text] [Related]
5. Microbiological control in stem cell banks: approaches to standardisation. Cobo F; Stacey GN; Hunt C; Cabrera C; Nieto A; Montes R; Cortés JL; Catalina P; Barnie A; Concha A Appl Microbiol Biotechnol; 2005 Sep; 68(4):456-66. PubMed ID: 16012832 [TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of the environmental bacterial and fungi contamination in a pharmaceutical unit of mesenchymal stem cell for clinical use. Martín PG; González MB; Martínez AR; Lara VG; Naveros BC Biologicals; 2012 Sep; 40(5):330-7. PubMed ID: 22795333 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic approaches for viruses and prions in stem cell banks. Cobo F; Talavera P; Concha A Virology; 2006 Mar; 347(1):1-10. PubMed ID: 16380145 [TBL] [Abstract][Full Text] [Related]
9. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications. Ausubel LJ; Lopez PM; Couture LA Methods Mol Biol; 2011; 767():147-59. PubMed ID: 21822873 [TBL] [Abstract][Full Text] [Related]
10. Ethics and Governance of Stem Cell Banks. Chalmers D; Rathjen P; Rathjen J; Nicol D Methods Mol Biol; 2017; 1590():99-112. PubMed ID: 28353264 [TBL] [Abstract][Full Text] [Related]
11. Manufacturing considerations for clinical uses of therapies derived from stem cells. Weber DJ Methods Enzymol; 2006; 420():410-30. PubMed ID: 17161709 [TBL] [Abstract][Full Text] [Related]
12. The UK Stem Cell Bank: its role as a public research resource centre providing access to well-characterised seed stocks of human stem cell lines. Healy L; Hunt C; Young L; Stacey G Adv Drug Deliv Rev; 2005 Dec; 57(13):1981-8. PubMed ID: 16290151 [TBL] [Abstract][Full Text] [Related]
16. Fundamental Principles of Stem Cell Banking. Sun C; Yue J; He N; Liu Y; Zhang X; Zhang Y Adv Exp Med Biol; 2016; 951():31-45. PubMed ID: 27837552 [TBL] [Abstract][Full Text] [Related]
17. Cell contamination leads to inaccurate data: we must take action now. Stacey GN Nature; 2000 Jan; 403(6768):356. PubMed ID: 10667765 [No Abstract] [Full Text] [Related]
18. The U.S. National biomonitoring specimen bank and the marine environmental specimen bank. Becker PR; Wise SA J Environ Monit; 2006 Aug; 8(8):795-9. PubMed ID: 16896462 [TBL] [Abstract][Full Text] [Related]
20. The impact of the congestion charging scheme on air quality in London. Part 1. Emissions modeling and analysis of air pollution measurements. Kelly F; Anderson HR; Armstrong B; Atkinson R; Barratt B; Beevers S; Derwent D; Green D; Mudway I; Wilkinson P; Res Rep Health Eff Inst; 2011 Apr; (155):5-71. PubMed ID: 21830496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]